基因编辑(BK4556)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4556 基因编辑

交易中 06-17 14:47:15 EDT

497.43

+26.81

+5.70%

最高512.87	最低468.80	成交量1,465万
今开472.55	昨收470.63	日振幅9.36%
总市值0.00	流通市值0.00	总股本0.00
成交额2.77亿	换手率--	流通股本0.00
市净率2.95031	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":497.4322,"timestamp":1781722035518,"preClose":470.6271,"halted":0,"volume":14650387,"delay":0,"changeRate":0.056956,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":26.805084,"latestTime":"06-17 14:47:15 EDT","open":472.5541,"high":512.86865,"low":468.8033,"amount":277149823.980415,"amplitude":0.093631,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781726400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.95031,"peRate":-9.343872,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4556/tweets","defaultTab":"tweets","newsList":[{"id":"1123375802","title":"Intellia Therapeutics旗下Haleo研究达到主要终点，Lonvo-Z组平均月发作次数降低87% (P<0.0001)","url":"https://stock-news.laohu8.com/highlight/detail?id=1123375802","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123375802?lang=zh_cn&edition=full","pubTime":"2026-06-13 19:37","pubTimestamp":1781350635,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics宣布，其Haleo研究成功达到主要终点。数据显示，在Lonvo-Z治疗组中，患者平均每月发作次数实现了高达87%的显著降低，且该结果具有高度统计学意义（P值小于0.0001）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4556","BK4535","LU1861559042.SGD","BK4588","NTLA","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122255214","title":"Intellia Therapeutics启动Lonvo-Z滚动BLA提交，预计2027年上半年在美国上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1122255214","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122255214?lang=zh_cn&edition=full","pubTime":"2026-06-13 19:33","pubTimestamp":1781350398,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics已正式启动其基因编辑疗法Lonvo-Z向美国食品药品监督管理局（FDA）的滚动生物制品许可申请（BLA）提交程序。这一关键步骤标志着该疗法向商业化迈出了重要一步。公司预计，若后续审查顺利，Lonvo-Z有望于2027年上半年在美国市场正式推出。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NTLA","BK4588","BK4556","BK4585","LU1861558580.USD","BK4535","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170241565","title":"Intellia Therapeutics公布Lonvoguran Ziclumeran (Lonvo-Z)治疗遗传性血管性水肿的3期试验更多积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1170241565","media":"美股速递","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170241565?lang=zh_cn&edition=full","pubTime":"2026-06-13 19:31","pubTimestamp":1781350278,"startTime":"0","endTime":"0","summary":"生物技术公司Intellia Therapeutics Inc公布了其候选疗法Lonvoguran Ziclumeran（研发代号Lonvo-Z）在治疗遗传性血管性水肿患者中的最新3期临床试验数据，结果显示出持续的积极疗效与安全性。\n此次公布的数据进一步巩固了该疗法在关键后期研究中的表现，为后续的监管申请提供了有力支持。遗传性血管性水肿是一种罕见的遗传性疾病，患者会反复出现皮下或黏膜下组织的严重肿胀，目前仍存在未满足的临床需求。\n公司表示，这些额外的积极结果增强了他们对Lonvo-Z潜力的信心，并计划持续推进相关开发工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU1861558580.USD","BK4556","BK4139","BK4588","NTLA","BK4585","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518748472","title":"Editas Medicine, Inc.盘中异动 股价大跌5.52%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518748472?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:51","pubTimestamp":1741618295,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时51分，Editas Medicine, Inc.股票出现波动，股价急速跳水5.52%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3498.05%、774.19%、704.07%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为45.34%、41.36%、40.33%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225135a26a4357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225135a26a4357&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518203826","title":"Crispr Therapeutics Ag盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518203826?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:49","pubTimestamp":1741618153,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时49分，Crispr Therapeutics Ag股票出现异动，股价大幅下跌5.01%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.22%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022491398a2b016&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022491398a2b016&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRSP","BK4585","BK4611","LENZ","BK4556","BK4588","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220291","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.20%报27.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220291?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615383,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分，Beam Therapeutics Inc.股票出现异动，股价急速下跌5.20%。截至发稿，该股报27.00美元/股，成交量237.165万股，换手率2.83%，振幅3.72%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4588","BK4505","LENZ","BK4585","BK4535","BK4611","BK4139","BEAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518272482","title":"Intellia Therapeutics, Inc.盘中异动 早盘快速跳水5.12%报9.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272482?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613523,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Intellia Therapeutics, Inc.股票出现异动，股价大幅下跌5.12%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213203abf2fc32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213203abf2fc32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861559042.SGD","LENZ","BK4588","LU1861558580.USD","BK4535","BK4556","BK4139","NTLA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517016551","title":"Crispr Therapeutics Ag盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517016551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517016551?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:41","pubTimestamp":1741272079,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时41分，Crispr Therapeutics Ag股票出现异动，股价快速下挫5.00%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.41%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224120963c4f33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224120963c4f33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1861559042.SGD","LENZ","CRSP","BK4556","BK4139","BK4585","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166011","title":"Intellia Therapeutics, Inc.盘中异动 早盘急速下挫5.18%报8.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166011?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:35","pubTimestamp":1741271743,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时35分，Intellia Therapeutics, Inc.股票出现异动，股价大幅跳水5.18%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223543989eb532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223543989eb532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1861559042.SGD","BK4556","NTLA","BK4585","BK4588","LU1861558580.USD","BK4535","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517200169","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517200169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517200169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271528,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Beam Therapeutics Inc.股票出现异动，股价大幅下挫5.09%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为953.51%、104.36%、48.88%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BEAM","BK4535","BK4139","BK4585","LENZ","BK4556","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517126165","title":"Sangamo Therapeutics, Inc.盘中异动 早盘急速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517126165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517126165?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271481,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Sangamo Therapeutics, Inc.股票出现异动，股价急速下挫5.13%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223121abeb7759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223121abeb7759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","LENZ","SGMO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517923427","title":"蓝鸟生物盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517923427?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:22","pubTimestamp":1741202566,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时22分，蓝鸟生物股票出现波动，股价大幅拉升5.24%。截至发稿，该股报4.02美元/股，成交量18.2446万股，换手率1.87%，振幅4.97%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为2.06%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tonix Pharmaceuticals Holding Corp.涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为960.68%、313.94%、307.90%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.，振幅分别为82.59%、54.27%、50.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032247963b1b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032247963b1b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4578","BK4139","BLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948568","title":"Editas Medicine, Inc.盘中异动 股价大涨5.11%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948568?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185053,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Editas Medicine, Inc.股票出现波动，股价大幅上涨5.11%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为311.45%、251.30%、184.61%，振幅较大的相关个股有Aditxt, Inc.、4D Molecular Therapeutics, Inc.、Creative Medical Technology Holdings, Inc.，振幅分别为10.04%、8.56%、8.18%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223053abe9b054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223053abe9b054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670089","title":"Beam Therapeutics Inc.盘中异动 早盘急速下挫5.18%报23.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670089?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:52","pubTimestamp":1741099972,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分，Beam Therapeutics Inc.股票出现异动，股价大幅跳水5.18%。截至发稿，该股报23.80美元/股，成交量20.2093万股，换手率0.24%，振幅2.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4585","BEAM","LENZ","BK4139","BK4556","BK4588","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516459677","title":"Sangamo Therapeutics, Inc.盘中异动 股价大跌5.46%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516459677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516459677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098687,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Sangamo Therapeutics, Inc.股票出现异动，股价快速跳水5.46%。截至发稿，该股报0.870美元/股，成交量10.655万股，换手率0.05%，振幅1.00%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223127a25f0422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223127a25f0422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","LENZ","SGMO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516619511","title":"数据：在PEPE、BEAM等代币上损失千万美元的巨鲸转向购买BTC和MKR","url":"https://stock-news.laohu8.com/highlight/detail?id=2516619511","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516619511?lang=zh_cn&edition=full","pubTime":"2025-03-04 12:42","pubTimestamp":1741063374,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896779398776512797","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4535","ETH.USD.HKCC","BK4139","BEAM","BTC","MKR.USD.HKCC","MKR.USD.CC","BK4588","BK4585","BTC.USD.HKCC","BTCmain","BK4556","ETH","BK4505","XBTmain","BK4601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663938","title":"Beam Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报24.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663938?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:28","pubTimestamp":1741033681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分，Beam Therapeutics Inc.股票出现波动，股价大幅跳水5.13%。截至发稿，该股报24.99美元/股，成交量81.582万股，换手率0.97%，振幅6.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BEAM","LENZ","BK4556","BK4505","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516657315","title":"Intellia Therapeutics, Inc.盘中异动 大幅下挫5.00%报9.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516657315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516657315?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:46","pubTimestamp":1741027611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时46分，Intellia Therapeutics, Inc.股票出现异动，股价快速跳水5.00%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024651989a4900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024651989a4900&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","LENZ","BK4585","LU1861559042.SGD","BK4556","NTLA","LU1861558580.USD","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516583936","title":"Editas Medicine, Inc.盘中异动 早盘大幅下跌5.15%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516583936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516583936?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:33","pubTimestamp":1741016000,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时33分，Editas Medicine, Inc.股票出现波动，股价大幅下跌5.15%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2111.16%、136.36%、127.52%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233320989a1ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233320989a1ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516632017","title":"蓝鸟生物盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516632017?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:45","pubTimestamp":1741013150,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时45分，蓝鸟生物股票出现异动，股价快速下跌5.82%。截至发稿，该股报3.84美元/股，成交量4.1416万股，换手率0.43%，振幅4.90%。机构评级方面，在所有7家参与评级的机构中，14%的券商给予买入建议，86%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224550989a1381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224550989a1381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4556","BK4578","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1344},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.245},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"基因编辑","nameEN":"BK4556"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基因编辑(BK4556)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基因编辑(BK4556)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基因编辑,BK4556,基因编辑股票,基因编辑股票老虎,基因编辑股票老虎国际,基因编辑行情,基因编辑股票行情,基因编辑股价,基因编辑股市,基因编辑股票价格,基因编辑股票交易,基因编辑股票购买,基因编辑股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基因编辑(BK4556)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基因编辑(BK4556)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}